Largest health care companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
UnitedHealth Group leads the 170 health care companies ranked by cash on hand, at SGD 31.4B, ahead of Johnson & Johnson (SGD 25.4B) and Centene (SGD 23B). Figures as of 20 Nov 2026, 12:56 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- UnitedHealth GroupSGD 31.4B
- Median
- SGD 747.9M
- Combined market value
- SGD 11.49T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Merit Medical SystemsMMSI · Health Care | SGD 575.1M | SGD 6.5B | SGD 108.75 | 1.77% down | 3% down | ||
| 102 | STERISSTE · Health Care | SGD 566.3M | SGD 31.9B | SGD 328.21 | 1.85% down | 3% down | ||
| 103 | Quest DiagnosticsDGX · Health Care | SGD 541.1M | SGD 36.7B | SGD 333.79 | 0.23% down | 35% up | ||
| 104 | AlkermesALKS · Health Care | SGD 500.6M | SGD 10B | SGD 59.50 | 1.43% down | 61% up | ||
| 105 | Revolution MedicinesRVMD · Health Care | SGD 494.4M | SGD 44.4B | SGD 205.40 | 0.24% down | 125% up | ||
| 106 | Bausch + LombBLCO · Health Care | SGD 493.4M | SGD 9.5B | SGD 26.66 | 1.24% down | 37% up | ||
| 107 | TeleflexTFX · Health Care | SGD 487.7M | SGD 8.3B | SGD 210.51 | 1.48% down | 48% up | ||
| 108 | Guardant HealthGH · Health Care | SGD 487.3M | SGD 25.4B | SGD 187.57 | 0.31% up | 38% up | ||
| 109 | Ionis PharmaceuticalsIONS · Health Care | SGD 479.6M | SGD 5.8B | SGD 35.07 | 0.62% down | 64% down | ||
| 110 | AvantorAVTR · Health Care | SGD 470.8M | SGD 13.2B | SGD 19.48 | 1.63% down | 31% up | ||
| 111 | Lantheus HoldingsLNTH · Health Care | SGD 462.7M | SGD 8.6B | SGD 131.54 | 0.10% up | 83% up | ||
| 112 | Praxis Precision MedicinesPRAX · Health Care | SGD 460.4M | SGD 11.2B | SGD 400.54 | 1.87% up | 83% up | ||
| 113 | Kymera TherapeuticsKYMR · Health Care | SGD 459.9M | SGD 13.1B | SGD 153.81 | 1.44% down | 81% up | ||
| 114 | Belite BioBLTE · Health Care | SGD 454.7M | SGD 7.9B | SGD 194.56 | 3.33% down | 25% up | ||
| 115 | CRISPR TherapeuticsCRSP · Health Care | SGD 447.8M | SGD 4.9B | SGD 50.15 | 3.14% down | 22% down | ||
| 116 | Scholar Rock HoldingSRRK · Health Care | SGD 416.8M | SGD 7.9B | SGD 64.89 | 4.94% up | 25% up | ||
| 117 | Axsome TherapeuticsAXSM · Health Care | SGD 416M | SGD 9.2B | SGD 174.80 | 1.25% up | 9% down | ||
| 118 | HealthEquityHQY · Health Care | SGD 410.9M | SGD 10.4B | SGD 125.46 | 0.07% up | 4% down | ||
| 119 | Cogent BiosciencesCOGT · Health Care | SGD 402M | SGD 6.2B | SGD 35.74 | 0.25% down | 25% down | ||
| 120 | BrukerBRKR · Health Care | SGD 385M | SGD 12.2B | SGD 80.01 | 1.83% down | 31% up | ||
| 121 | MiniMed GroupMMED · Health Care | SGD 383.9M | SGD 5.9B | SGD 20.95 | 4.30% down | 12% down | ||
| 122 | Mirum PharmaceuticalsMIRM · Health Care | SGD 382.2M | SGD 8B | SGD 123.05 | 3.27% up | 35% up | ||
| 123 | Amneal PharmaceuticalsAMRX · Health Care | SGD 363.3M | SGD 9.6B | SGD 27.56 | 2.24% down | 79% up | ||
| 124 | Bio-TechneTECH · Health Care | SGD 341M | SGD 14.7B | SGD 93.66 | 0.07% down | 18% up | ||
| 125 | Definium TherapeuticsDFTX · Health Care | SGD 332.2M | SGD 5.2B | SGD 37.98 | 1.24% up | 176% up | ||
| 126 | GRAILGRAL · Health Care | SGD 321.7M | SGD 6.1B | SGD 135.07 | 2.68% up | 12% up | ||
| 127 | LifeStance Health GroupLFST · Health Care | SGD 320.3M | SGD 6.5B | SGD 17.19 | 3.12% down | 107% up | ||
| 128 | HaemoneticsHAE · Health Care | SGD 316.2M | SGD 7.1B | SGD 155.08 | 2.03% down | 53% up | ||
| 129 | Option Care HealthOPCH · Health Care | SGD 299.7M | SGD 6.1B | SGD 40.72 | 0.32% down | 7% up | ||
| 130 | Hims & Hers HealthHIMS · Health Care | SGD 294.5M | SGD 4.8B | SGD 20.64 | 6.04% down | 54% down | ||
| 131 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 291.9M | SGD 7.9B | SGD 56.24 | 1.25% up | 8% up | ||
| 132 | Summit TherapeuticsSMMT · Health Care | SGD 290.2M | SGD 10.9B | SGD 13.62 | 0.67% up | 35% down | ||
| 133 | Charles River Laboratories InternationalCRL · Health Care | SGD 275.4M | SGD 20.2B | SGD 422.48 | 1.60% down | 96% up | ||
| 134 | Kodiak SciencesKOD · Health Care | SGD 270.4M | SGD 8.2B | SGD 126.13 | 0.09% up | 371% up | ||
| 135 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 256M | SGD 11.9B | SGD 511.13 | 0.34% down | 28% down | ||
| 136 | PACS GroupPACS · Health Care | SGD 253.8M | SGD 8.8B | SGD 55.44 | 7.06% down | 56% up | ||
| 137 | PenumbraPEN · Health Care | SGD 240.8M | SGD 16.2B | SGD 412.28 | 0.18% down | 11% up | ||
| 138 | Twist BioscienceTWST · Health Care | SGD 235.8M | SGD 9.8B | SGD 143.80 | 4.07% down | 291% up | ||
| 139 | IDEXX LaboratoriesIDXX · Health Care | SGD 232M | SGD 70B | SGD 888.50 | 1.26% down | 5% down | ||
| 140 | Ligand PharmaceuticalsLGND · Health Care | SGD 225.4M | SGD 7.4B | SGD 369.67 | 3.94% down | 44% up | ||
| 141 | VaxcytePCVX · Health Care | SGD 224.1M | SGD 11.9B | SGD 75.19 | 0.27% down | 22% up | ||
| 142 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 213.3M | SGD 9.5B | SGD 120.50 | 1.59% down | 125% up | ||
| 143 | MSA SafetyMSA · Health Care | SGD 212.7M | SGD 8.7B | SGD 227.06 | 0.68% down | 13% up | ||
| 144 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 210.7M | SGD 15.9B | SGD 19.11 | 1.00% down | 7% up | ||
| 145 | Henry ScheinHSIC · Health Care | SGD 201M | SGD 12.1B | SGD 109.25 | 1.04% down | 16% up | ||
| 146 | Universal Health ServicesUHS · Health Care | SGD 177.5M | SGD 13B | SGD 225.43 | 5.96% down | 25% down | ||
| 147 | Halozyme TherapeuticsHALO · Health Care | SGD 172.4M | SGD 13.7B | SGD 119.87 | 2.88% down | 32% up | ||
| 148 | Protagonist TherapeuticsPTGX · Health Care | SGD 165.4M | SGD 10.4B | SGD 159.78 | 2.47% down | 45% up | ||
| 149 | CytokineticsCYTK · Health Care | SGD 157.8M | SGD 9.2B | SGD 66.30 | 0.27% up | 21% down | ||
| 150 | Corcept TherapeuticsCORT · Health Care | SGD 155.2M | SGD 9.2B | SGD 83.72 | 4.15% down | 16% down | ||
| 151 | Cooper CompaniesCOO · Health Care | SGD 142.5M | SGD 14.8B | SGD 77.72 | 0.69% down | 20% down | ||
| 152 | Travere TherapeuticsTVTX · Health Care | SGD 119.9M | SGD 6B | SGD 62.23 | 3.86% down | 39% up | ||
| 153 | GlaukosGKOS · Health Care | SGD 117M | SGD 18.2B | SGD 306.75 | 2.15% up | 139% up | ||
| 154 | BrightSpring Health ServicesBTSG · Health Care | SGD 113.8M | SGD 16.4B | SGD 82.48 | 6.32% down | 85% up | ||
| 155 | ImmunityBioIBRX · Health Care | SGD 113.8M | SGD 9B | SGD 8.46 | 1.94% down | 216% up | ||
| 156 | Spyre TherapeuticsSYRE · Health Care | SGD 110.4M | SGD 11.9B | SGD 125.78 | 3.77% down | 302% up | ||
| 157 | Concentra Group Holdings ParentCON · Health Care | SGD 102.9M | SGD 6.7B | SGD 53.40 | 1.12% down | 105% up | ||
| 158 | TG TherapeuticsTGTX · Health Care | SGD 102M | SGD 12.6B | SGD 83.59 | 1.88% down | 103% up | ||
| 159 | ChemedCHE · Health Care | SGD 96M | SGD 9.2B | SGD 710.29 | 0.84% up | 25% up | ||
| 160 | ErascaERAS · Health Care | SGD 95.1M | SGD 6.4B | SGD 18.32 | 3.34% up | 387% up | ||
| 161 | Encompass HealthEHC · Health Care | SGD 93M | SGD 16.7B | SGD 170.42 | 1.96% down | 16% up | ||
| 162 | Adaptive BiotechnologiesADPT · Health Care | SGD 90.8M | SGD 5.8B | SGD 36.14 | 1.44% down | 51% up | ||
| 163 | Mettler-Toledo InternationalMTD · Health Care | SGD 86.2M | SGD 43.7B | SGD 2,197.45 | 1.82% down | 17% up | ||
| 164 | Edgewise TherapeuticsEWTX · Health Care | SGD 78.8M | SGD 5.8B | SGD 53.04 | 0.48% down | 82% up | ||
| 165 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 70M | SGD 10.4B | SGD 150.48 | 1.88% down | 15% up | ||
| 166 | Dianthus TherapeuticsDNTH · Health Care | SGD 65.8M | SGD 6.2B | SGD 109.29 | 1.01% up | 105% up | ||
| 167 | Oruka TherapeuticsORKA · Health Care | SGD 60.5M | SGD 8.5B | SGD 125.70 | 1.91% up | 233% up | ||
| 168 | HeartflowHTFL · Health Care | SGD 57.7M | SGD 5.1B | SGD 57.50 | 2.75% down | 45% up | ||
| 169 | CG OncologyCGON · Health Care | SGD 41.9M | SGD 9.4B | SGD 105.51 | 2.38% up | 93% up | ||
| 170 | VeradermicsMANE · Health Care | SGD 28M | SGD 6.8B | SGD 160.26 | 0.38% down | 230% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2883 SGD).
Questions and answers
Which health care companies rank first by cash on hand?
UnitedHealth Group (SGD 31.4B), Johnson & Johnson (SGD 25.4B) and Centene (SGD 23B) are the top three of the 170 health care companies ranked by cash on hand as of 20 Nov 2026, 12:56 UTC.
How many health care companies are in this ranking?
170 are ranked by cash on hand.
What are these health care companies worth together?
The 170 health care companies ranked by cash on hand have a combined market value of SGD 11.49T as of 20 Nov 2026, 12:56 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest health care companies by cash on hand”, data as of 20 November 2026. https://funkfolio.com/companies/sector/health-care?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.